Black Patches on Soles of Feet: Causes, Diagnosis, and When to Worry

Noticing a new black patch on the sole of your foot can be unsettling. While your mind might jump to the worst-case scenario, it's important to know that the causes for these spots range from completely benign to serious medical conditions that require prompt attention. The soles of the feet endure constant mechanical stress, moisture exposure, and pressure, making them highly susceptible to a variety of dermatological and systemic changes. Dark discoloration can arise from minor trauma, fungal colonization, viral infections, chronic friction, vascular compromise, or, in rare but critical instances, malignant transformation. Understanding the potential reasons, recognizing the clinical hallmarks of each condition, and knowing precisely when to seek professional medical advice is the first step in protecting your long-term health and mobility.

This comprehensive guide synthesizes peer-reviewed medical literature, clinical guidelines, expert dermatological and podiatric advice, and real-world patient experiences to help you navigate what a black patch on your foot might mean, how it is evaluated in a clinical setting, and when you should schedule an in-person examination with a qualified healthcare provider.

Common and Benign Causes of Black Patches on Feet

Many dark spots on the feet are harmless and result from everyday life, environmental exposures, or minor skin conditions that resolve with appropriate conservative management. Distinguishing these from more concerning lesions requires an understanding of the underlying mechanisms and typical clinical courses.

Trauma and Bruising

The simplest and most frequent explanation is direct or repetitive trauma. The thick, glabrous (hairless) skin on the plantar surface is densely packed with capillary networks and lacks the protective cushioning of adipose tissue found elsewhere on the body. Stepping on a small, sharp object, dropping a heavy item on the foot, or enduring repeated impact from running, jumping, or wearing rigid-soled footwear can cause tiny blood vessels (capillaries and venules) beneath the epidermis to rupture. When blood escapes into the dermal or epidermal layers, it undergoes a predictable biochemical degradation process. Hemoglobin breaks down into biliverdin and bilirubin, which clinically manifests as a color transition from deep red or purple to blue, green, yellow, and finally brown or black before fading completely.

A localized collection of blood within a blister cavity, known as a blood blister or subcorneal hematoma, is particularly common on weight-bearing areas like the metatarsal heads and heels. Unlike true hematomas that sit deeper in the tissue, blood blisters form when the top layers of skin separate from the layers beneath due to shear forces, creating a pocket that fills with blood. These lesions are typically tender or mildly painful upon initial formation but gradually lose sensitivity as the overlying keratin layer thickens and the body reabsorbs the pooled blood. Healing timelines vary based on individual circulation, the extent of the injury, and whether further mechanical stress is applied to the area. In most cases, resolution occurs within two to eight weeks. Applying the RICE protocol (Rest, Ice, Compression, Elevation) in the acute phase and protecting the area with padded insoles or cushioned socks can accelerate recovery. However, if a "bruise" fails to follow a predictable healing trajectory, spreads, or appears without any plausible trauma, it warrants clinical evaluation to rule out vascular abnormalities or pigmented lesions.

Hyperpigmentation due to Friction

Constant pressure and repetitive mechanical friction from ill-fitting shoes, high-impact activities, or altered gait mechanics can trigger a physiological response known as reactive melanogenesis and keratinization. The plantar epidermis responds to chronic stress by thickening the stratum corneum (the outermost layer of skin), forming calluses or corns. Simultaneously, local melanocytes—the pigment-producing cells in the basal layer of the epidermis—may become hyperactive in response to micro-inflammation and repeated cellular turnover. This phenomenon, classified as frictional melanosis or post-inflammatory hyperpigmentation, leads to dark, patchy discoloration that aligns precisely with weight-bearing zones or areas where shoe uppers rub against the foot.

Frictional melanosis is particularly prevalent among athletes, individuals who stand for prolonged occupational hours, and those who frequently wear footwear with inadequate arch support or narrow toe boxes. The discoloration is typically uniform, asymptomatic (aside from possible callus-related discomfort), and lacks the irregular borders or variegated coloring associated with malignant conditions. Over time, these patches may darken further if the mechanical insult continues unchecked. Management focuses heavily on mechanical offloading: transitioning to properly fitted shoes with adequate toe room, using silicone gel pads or custom orthotics to redistribute plantar pressure, and gently reducing hyperkeratotic tissue with emollients containing urea (10-40%) or salicylic acid. It is crucial to note that aggressive scraping, cutting, or using unsterilized bathroom razors on callused dark patches can introduce bacteria, cause micro-tears, and paradoxically worsen hyperpigmentation through further post-inflammatory response. If discoloration persists despite proper footwear modification and pressure relief, or if the patch begins to change in morphology, a dermatological assessment is recommended.

An image of a brown or black patch caused by tinea nigra on the sole of a foot. Image Source: Medical News Today

Fungal Infections (Tinea Nigra)

Tinea nigra is a rare, superficial, non-inflammatory fungal infection caused by the dematiaceous (pigmented) fungus Hortaea werneckii, formerly known as Exophiala werneckii. This organism is halophilic and thrives in warm, humid, and saline environments, making it endemic in tropical and subtropical coastal regions worldwide. Unlike deeper dermatophyte infections that invade hair follicles and nail beds, H. werneckii colonizes strictly within the stratum corneum, feeding on keratin without penetrating living tissue or triggering a robust immune response. Consequently, tinea nigra presents as a painless, flat, brown to black macular patch that closely resembles an ink stain or dried blood. The lesion typically grows slowly, measuring between 1 and 5 centimeters, with a slightly raised, well-demarcated, and sometimes geographic or serpiginous border. Crucially, the surface is smooth, non-scaly, and completely asymptomatic regarding itching or tenderness.

Because tinea nigra lacks the classic signs of inflammation (rubor, calor, dolor, tumor) and does not respond to typical antibacterial or anti-inflammatory creams, patients often delay seeking care or mistakenly apply home remedies that can obscure diagnosis. Transmission occurs through direct inoculation of fungal spores into minor epidermal abrasions, frequently following contact with contaminated soil, decaying vegetation, shower floors, or swimming pool decks. In clinical practice, diagnosis is confirmed via a potassium hydroxide (KOH) wet mount preparation, where skin scrapings from the patch reveal short, septate, pigmented hyphae and yeast-like cells against a clear background. Wood's lamp examination is notably unhelpful, as H. werneckii does not fluoresce. Treatment is highly effective and typically involves topical antifungal agents such as ketoconazole 2%, ciclopirox 1%, or terbinafine cream applied twice daily for two to four weeks. In refractory cases, oral itraconazole may be prescribed. Recurrence is uncommon once the environment is addressed and complete eradication is achieved. Patients are advised to keep the plantar surface dry, wear moisture-wicking socks, avoid walking barefoot in public damp areas, and thoroughly disinfect footwear.

Plantar Warts

Plantar warts (verruca plantaris) are extremely common, benign epithelial proliferations caused by specific strains of the human papillomavirus (HPV), most frequently types 1, 2, 4, 27, and 57. The virus enters the body through microtraumas, cuts, or abrasions on the moist, macerated skin of the feet, particularly around communal shower areas, gym mats, and pool decks. Due to the constant downward pressure exerted by body weight during standing and walking, plantar warts do not protrude outward like common warts; instead, they are forced inward, creating a callus-like plaque that can cause significant discomfort akin to walking on a pebble.

While the wart tissue itself is typically flesh-colored, yellowish, or tan, it classically contains multiple pinpoint black dots scattered throughout its core. These are frequently misidentified as "wart seeds" by patients, but they are actually thrombosed (clotted) dermal capillaries that have been stretched and compressed into the lesion. When the hyperkeratotic surface is gently pared down by a clinician, these black dots become more visible and serve as a key diagnostic differentiator from corns, calluses, and melanocytic lesions. In cases where multiple warts coalesce, forming a mosaic wart, the clustered appearance of thrombosed vessels can occasionally create an overall darkened or mottled appearance that mimics a pigmented patch.

Plantar warts often regress spontaneously within one to two years due to cell-mediated immune clearance, but many patients seek intervention due to pain, cosmetic concern, or fear of transmission. First-line over-the-counter treatments typically involve daily application of salicylic acid (17-40%) following periodic soaking and gentle debridement. Clinical modalities include cryotherapy with liquid nitrogen, cantharidin blistering agents, laser ablation (CO2 or pulsed dye), intralesional bleomycin, immunotherapy with Candida or mumps antigen, and surgical curettage. Success rates vary, and recurrence is common if viral reservoirs in surrounding skin remain untreated. Prevention hinges on maintaining intact plantar skin barriers, using protective footwear in shared wet environments, avoiding picking or scratching warts, and practicing rigorous foot hygiene.

Serious Causes Requiring Medical Attention

While less common, a black patch can be a sign of a serious underlying medical condition. Early diagnosis is critical for effective treatment, as delays can significantly impact prognosis, particularly in cases involving malignancy or vascular compromise.

Acral Lentiginous Melanoma (ALM)

This is the most serious potential cause of a black patch on the sole of the foot. Acral lentiginous melanoma (ALM) is a rare but aggressive form of cutaneous melanoma that arises specifically on glabrous (hairless) skin, namely the palms, soles, and nail beds (subungual melanoma). Unlike the more common superficial spreading or nodular melanomas, ALM is not strongly associated with cumulative ultraviolet (UV) radiation exposure or intermittent sunburns. The exact etiology remains poorly understood, though genetic mutations in genes such as KIT, NRAS, and BRAF, along with chronic mechanical trauma, are hypothesized to play contributory roles.

Clinically, ALM often begins as an irregularly pigmented macule that slowly evolves. Over months to years, it may develop into a thicker, palpable nodule or plaque, potentially ulcerating or bleeding in advanced stages. Because the stratum corneum on the sole is exceptionally thick, early lesions can be obscured by overlying keratin, leading to misdiagnosis as a blood blister, bruise, wart, or fungal infection.

Demographic Disparities and Diagnostic Challenges

Unlike other melanomas linked to sun exposure, ALM is not. It is the most common type of melanoma in people with darker skin tones, including individuals of African, Asian, and Hispanic descent, accounting for approximately 35-70% of melanomas in these populations. In contrast, it represents only 1-5% of melanomas in fair-skinned Caucasian populations. The tragic death of musician Bob Marley at age 36 from ALM that began under his toenail brought global attention to this disease and highlighted how aggressive subungual and acral melanomas can be when initially dismissed as athletic injuries.

Unfortunately, diagnosis is frequently delayed in people of color, leading to significantly thicker Breslow depths at presentation, higher rates of regional lymph node involvement, and poorer overall survival outcomes. This diagnostic delay stems from multiple intersecting factors: a pervasive lack of public awareness that skin cancer can occur on sun-protected, heavily pigmented areas; implicit bias in healthcare settings; inadequate representation of ALM and melanoma on darker skin in medical textbooks, board examinations, and public health campaigns; and the clinical mimicry of ALM to benign dermatoses. As college football player Joshua Paschal, who was diagnosed with ALM on his foot, told TODAY.com, he initially dismissed the spot as a blood blister from cleat pressure, underscoring how easily athletic populations can normalize early warning signs.

How to Spot Potential Melanoma: ABCDE vs. CUBED

Dermatologists use two acronyms to identify suspicious lesions. Because plantar anatomy and frictional changes alter the classic presentation of melanoma, specialized criteria have been developed to improve early detection on the feet.

The ABCDEs of Melanoma:

• Asymmetry: One half of the spot does not match the other when bisected by an imaginary line. Benign moles and bruises tend to be symmetrical.
• Border: The edges are irregular, ragged, notched, scalloped, or blurred. Malignant lesions often invade surrounding tissue unevenly.
• Color: The color is not uniform and may include shades of black, brown, tan, pink, red, white, gray, or blue within a single lesion. Multiple hues indicate active melanocytic proliferation at varying depths.
• Diameter: The spot is larger than 6 millimeters across (about the size of a pencil eraser), although early melanomas can be smaller when first detected. Rapid enlargement is a red flag.
• Evolving: The mole or patch is changing in size, shape, elevation, color, or symptoms (itching, bleeding, crusting) over days to weeks. Evolution is the single most critical indicator of malignancy.

An illustration comparing a normal mole to a cancerous melanoma using the ABCDE guidelines. Image Source: Skin Cancer Foundation

Because ALM can present differently, podiatrists and dermatologists developed the CUBED guide specifically for lesions on the feet:

• Colored: The lesion is a distinctly different color than the surrounding skin, often appearing dark brown, blue-black, or multicolored. Pigmentation may track along dermatoglyphic ridges (parallel ridge pattern on dermatoscopy).
• Uncertain: The diagnosis is unclear, atypical, or does not fit a classic benign pattern. When clinical doubt exists, biopsy is indicated rather than observation.
• Bleeding: The lesion is spontaneously bleeding, oozing serosanguinous fluid, or forming a crust without preceding significant trauma.
• Enlargement: The lesion or adjacent ulcer is progressively expanding, thickening, or failing to respond to standard wound care or conservative treatments over a 30 to 60-day period.
• Delay: A lesion, ulcer, or perceived "injury" takes more than two months to heal despite appropriate offloading, hygiene, and basic medical care. Chronic non-healing wounds on the foot are a major red flag for malignancy or ischemia.

Vascular and Systemic Conditions

Poor circulation can cause skin discoloration on the lower extremities. The vascular system delivers oxygenated blood to tissues and returns deoxygenated blood to the heart. When this hemodynamic balance is disrupted by valve incompetence, arterial plaque, or systemic metabolic disease, tissue hypoxia and hemosiderin deposition occur, manifesting as dark patches on the skin.

Venous Stasis Dermatitis

According to the Center for Vascular Medicine, this condition occurs when faulty valves in the deep and superficial leg veins allow blood to pool and leak into the surrounding dermal tissue (extravasation). The hydrostatic pressure damages capillary walls, causing red blood cells to escape into the interstitium. Macrophages break down the extravasated RBCs, leaving behind hemosiderin, an iron-storage complex that stains the skin a permanent reddish-brown, purplish, or slate-gray color. This pigmentation is typically bilateral, asymmetric but widespread, and accompanied by dependent edema, varicose veins, skin induration (lipodermatosclerosis), eczema-like scaling, and intense pruritus. While it primarily affects the medial malleolus, shins, and ankles, severe cases can extend to the dorsal and plantar foot surfaces. Venous stasis dermatitis is a clear clinical marker of chronic venous insufficiency (CVI) and carries a high risk of progressing to painful venous leg ulcers if unmanaged. Treatment focuses on compression therapy (graduated stockings), leg elevation, weight management, skin moisturization with barrier creams, and, in advanced cases, venous ablation or sclerotherapy.

Diabetic Foot Complications

People with diabetes mellitus are at exceptionally high risk for foot pathology due to the synergistic effects of chronic hyperglycemia, microvascular disease, peripheral neuropathy, and impaired immune function. Elevated blood glucose damages peripheral nerves over time, leading to a symmetrical, stocking-distribution loss of protective sensation (peripheral sensory neuropathy). Patients may unknowingly sustain repeated trauma, develop pressure points from ill-fitting shoes, or fail to notice foreign objects, blisters, or minor cuts. Concurrently, peripheral arterial disease (PAD) narrows the small vessels supplying the feet, reducing oxygen delivery, impairing wound healing, and limiting antibiotic efficacy.

A new black patch on a diabetic foot can indicate several alarming scenarios. It may represent a developing neuropathic ulcer with overlying necrotic eschar (dead tissue), a localized infection progressing to wet gangrene, or ischemic gangrene from complete arterial occlusion. Gangrenous tissue appears dry, shriveled, and black due to tissue necrosis and lack of perfusion. In diabetic patients, the transition from a minor lesion to limb-threatening infection can occur rapidly due to impaired leukocyte function and high bacterial load in warm, moist foot environments. Any person with diabetes who notices a new dark spot, especially one accompanied by warmth, foul odor, drainage, loss of sensation, or systemic symptoms like fever, must seek immediate medical care from a wound care specialist, podiatrist, or emergency department. Diabetic foot care protocols emphasize daily visual inspections (using a mirror for the soles if necessary), strict glycemic control, professional nail and callus care, moisture management, and the use of therapeutic, custom-fitted diabetic footwear.

When to See a Doctor or Podiatrist

Given the possibility of a serious condition like melanoma, advanced peripheral artery disease, or diabetic tissue compromise, a "wait and see" approach is strongly discouraged for unexplained plantar pigmentation. Early intervention dramatically alters clinical trajectories, whether the diagnosis is benign or malignant. You should schedule a prompt appointment with a board-certified dermatologist or podiatrist if you notice a spot that:

• Is new, unprovoked, and has no obvious cause (like a documented, healing injury from recent activity).
• Is actively changing in size, shape, elevation, texture, or color intensity over weeks.
• Matches any of the ABCDE or CUBED warning signs for melanoma or chronic foot pathology.
• Is persistently painful, itchy, tender to palpation, warm to the touch, or spontaneously bleeding/crusting.
• Is an open sore, fissure, or ulcer that fails to show progressive granulation tissue formation despite two weeks of diligent wound care and pressure relief.
• You have a personal history of dysplastic nevi (atypical moles) or a family history of melanoma, particularly first-degree relatives.
• You have an underlying systemic condition like diabetes mellitus, peripheral artery disease, chronic venous insufficiency, autoimmune disease, or are taking immunosuppressive medications (e.g., biologics, chemotherapy, corticosteroids).

The most important rule is: when in doubt, get it checked out. Clinicians would always prefer to biopsy a harmless lesion than miss an early malignancy. During your appointment, bring photographs documenting the lesion's progression over time, list all current medications and supplements, and wear the footwear you use daily to allow the provider to assess gait and pressure points.

Diagnosis and Treatment

A doctor will start with a comprehensive physical examination, reviewing your medical history, occupational activities, footwear habits, and symptom timeline. They will palpate the lesion, assess peripheral pulses (dorsalis pedis and posterior tibial), evaluate capillary refill, test sensory perception using a monofilament, and examine proximal lymph nodes for enlargement.

The cornerstone of non-invasive evaluation is dermoscopy (epiluminescence microscopy). The clinician uses a dermatoscope, a handheld optical device with polarized light and magnification, to visualize subsurface structures invisible to the naked eye. In benign traumatic lesions, dermoscopy reveals homogeneous red-purple lacunae. In tinea nigra, it shows a parallel furrow pattern with pigmentation confined to the sulci. In plantar warts, thrombosed capillaries appear as red-to-black dots with interrupted skin lines. In acral melanoma, the hallmark finding is the parallel ridge pattern (pigmentation accentuated on the cristae superficialis), which is highly predictive of malignancy on glabrous skin.

However, visual and dermoscopic assessment, while highly valuable, cannot definitively confirm or exclude cancer. The only way to definitively diagnose melanoma or characterize an atypical pigmented lesion is with a skin biopsy. This is a straightforward outpatient procedure performed under local anesthesia. Depending on the lesion's characteristics and size, the clinician may perform an excisional biopsy (removing the entire lesion with narrow margins), a punch biopsy (cylindrical core sample), or a shallow shave biopsy. The specimen is then processed by a histopathologist who examines it under a microscope, evaluating cellular atypia, mitotic rate, Breslow thickness, and ulceration status. If malignancy is confirmed, sentinel lymph node biopsy and staging imaging (CT, PET-CT, or MRI) may be recommended to assess metastatic spread.

• Benign Patches: If the spot is benign, treatment is tailored to the underlying etiology. Traumatic blood blisters resolve spontaneously with protective padding and activity modification. Frictional hyperpigmentation fades over months with mechanical offloading, proper footwear, and topical depigmenting agents like hydroquinone or kojic acid if cosmetically distressing. Fungal infections like tinea nigra clear with a 2-4 week course of topical antifungals and environmental decontamination. Plantar warts are managed through keratolytic agents, cryotherapy, immunotherapy, or surgical removal based on patient tolerance and lesion burden.
• Serious Conditions: If the diagnosis is melanoma, a multidisciplinary oncology team will stage the cancer and determine the appropriate intervention. Wide local excision with tumor-specific margins is standard. Depending on stage, adjuvant therapies may include targeted therapy (BRAF/MEK inhibitors), immunotherapy (PD-1 inhibitors like pembrolizumab or nivolumab), or localized radiation. For vascular conditions or diabetic foot complications, management requires systemic intervention: revascularization procedures (angioplasty, stenting, or bypass surgery) for arterial insufficiency, aggressive compression therapy for venous disease, meticulous offloading with total contact casts, advanced wound dressings, hyperbaric oxygen therapy, and tight metabolic control to prevent recurrence and limb loss. Regular surveillance, typically every 3 to 12 months depending on risk stratification, ensures long-term foot health and early detection of new lesions.

Frequently Asked Questions

Can a black patch on my foot be a sign of diabetes?

Yes, indirectly and directly. Uncontrolled diabetes damages peripheral nerves and blood vessels, significantly increasing the risk of foot complications. A black patch may represent necrotic tissue (gangrene) from severely restricted blood flow, or a non-healing neuropathic ulcer covered by eschar (dead, dried tissue). Because diabetic neuropathy often eliminates pain sensation, patients may not realize tissue damage has occurred until visual discoloration appears. Any new dark spot in a diabetic patient requires immediate clinical evaluation to prevent infection, osteomyelitis, or amputation.

How long does it take for a bruise on the sole of the foot to fade completely?

Plantar bruises typically follow a predictable color-changing cycle as hemoglobin breaks down, usually resolving within two to six weeks. However, because the sole of the foot is subjected to constant weight-bearing and friction, healing can be delayed compared to bruises on less active areas of the body. If a bruise does not show noticeable improvement after four weeks, if it expands rather than contracts, or if you have no memory of injuring your foot, you should consult a healthcare provider to rule out other pigmented conditions or vascular issues.

Are home remedies effective for treating black patches on feet?

Home remedies vary widely in safety and efficacy. For confirmed, minor conditions like friction calluses, daily soaking, gentle exfoliation with a pumice stone, and application of urea-based moisturizers are safe and beneficial. Over-the-counter salicylic acid can effectively treat common plantar warts when used consistently. However, applying harsh chemicals, cutting lesions with unsterilized tools, or using undiluted essential oils can cause severe irritation, chemical burns, infection, and permanent scarring. Crucially, attempting to treat an undiagnosed black patch at home can delay the diagnosis of serious conditions like melanoma. Always obtain a professional diagnosis before initiating treatment.

Why is acral lentiginous melanoma so often misdiagnosed?

ALM is frequently misdiagnosed due to a combination of clinical mimicry, anatomical location, and systemic healthcare gaps. On the thick, weight-bearing skin of the sole, ALM often presents without the classic sun-damage warning signs and can easily resemble benign blood blisters, plantar warts, calluses, or fungal stains. Both patients and clinicians may initially attribute it to athletic trauma. Additionally, public health messaging historically emphasized UV-related melanomas on the back, chest, and face, leaving sun-protected areas overlooked. In patients with darker skin tones, implicit bias and lack of training in recognizing melanoma on highly pigmented skin further compound diagnostic delays, allowing the cancer to advance to deeper, more dangerous stages before intervention.

Should I have a black patch biopsied if my doctor suspects it's just a blood blister?

Yes, if there is any clinical uncertainty, a biopsy is the safest and most definitive course of action. Dermatology and podiatry guidelines strongly advocate for a low threshold to biopsy atypical or non-healing pigmented lesions on the feet. Blood blisters have a predictable resolution timeline and clear history of trauma. If a lesion lacks a clear injury mechanism, fails to follow the normal healing trajectory, or exhibits dermoscopic features of melanoma (such as a parallel ridge pattern), a biopsy is medically necessary. A minor, locally anesthetized biopsy carries minimal risk and provides peace of mind or enables life-saving early intervention.

Conclusion

Discovering a black patch on the sole of your foot is understandably concerning, but it is important to approach the situation with informed caution rather than panic. The plantar surface of the foot is subjected to unique mechanical, environmental, and physiological stresses that can lead to a wide spectrum of conditions. While the majority of dark patches stem from benign origins such as minor trauma, friction-induced hyperpigmentation, common fungal colonization like tinea nigra, or viral plantar warts, it is imperative to rule out serious pathologies. Conditions like acral lentiginous melanoma, though rare, demand urgent recognition due to their aggressive nature and the historical delays in diagnosis, particularly among marginalized populations. Additionally, systemic vascular diseases and diabetic complications can manifest as localized discoloration, signaling underlying ischemia or tissue necrosis that requires immediate medical intervention.

Key to protecting your foot health is regular self-examination, understanding the warning signs outlined in the ABCDE and CUBED guidelines, and recognizing that any new, evolving, or non-healing lesion warrants professional evaluation. Modern diagnostic tools like dermoscopy and skin biopsies provide highly accurate, rapid differentiation between harmless discoloration and malignant disease. Treatment pathways are equally diverse and effective when matched to the correct diagnosis, ranging from conservative footwear modifications and topical antifungals to advanced surgical oncology and multidisciplinary vascular management. By staying vigilant, prioritizing proper foot hygiene, wearing supportive and correctly fitted footwear, and promptly consulting dermatologists or podiatrists for suspicious changes, you can ensure optimal outcomes and maintain long-term mobility. Never ignore persistent foot changes; early action is consistently the most powerful predictor of successful recovery.

References

• Center for Vascular Medicine - What Are Dark Spots on Bottom or Top of Feet?
• Medical News Today - Tinea nigra: Diagnosis, treatment, and remedies
• Fox Vein & Laser Experts - What Causes Brown & Dark Spots on Bottom of Feet?
• TODAY.com - Small dot turned out to be deadly melanoma hiding on the sole of his foot
• Consumer Reports - For Black People, Surviving Skin Cancer Begins With Knowing What to Look For—and Where
• American Academy of Dermatology - Signs that could be melanoma on your foot